September 13, 2020
Key note by Francesco Patalano (Novartis) and Daniel Prieto-Alhambra (University of Oxford). Albeit our different perspectives, we, public and private partners in EU-PEARL share a common responsibility towards society: to improve health outcomes for patients by promoting innovative and more efficient methodologies that enable the timely development of new medicines. Now, the COVID-19 global emergency...
Read More

Sign up to stay informed